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The Competitive Nature of HOXB4-Transduced HSC Is
Limited by PBX1: The Generation of Ultra-Competitive
Stem Cells Retaining Full Differentiation Potential
cant advantages. There is thus significant interest in
identifying factors that would contribute to the expan-
sion of HSCs.
Although considerable progress has been made to-
ward identifying cytokine combinations that maintain or
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moderately expand hemopoietic stem cells (HSCs) inClinical Research Institute of Montre´al
vitro (Conneally et al., 1997; Miller and Eaves, 1997),Montre´al, Que´bec
the culture conditions that enable significant ex vivoCanada H2W 1R7
expansion of HSCs remain to be defined. A number of2 Terry Fox Laboratory
studies suggest that HSC expansion can be achievedBritish Columbia Cancer Agency
by the activation of cell intrinsic pathways. ActivationVancouver, British Columbia
of Notch-1 in response to soluble Jagged-1 added toCanada V5Z 1L3
culture media resulted in expansion of multipotent col-3 Department of Medicine and
ony-forming cells (CFC) and maintenance of HSCs with4 Division of Hematology
lympho-myeloid repopulation potential (Karanu et al.,Hospital Maisonneuve-Rosemont, Montre´al
2000; Varnum-Finney et al., 2000). Increased self-renewalUniversite´ de Montre´al
of human HSCs was also documented in cultures sup-Montre´al, Que´bec
plemented with soluble Sonic Hedgehog (Shh) (Bhard-Canada H3C 3J7
waj et al., 2001). However, the magnitude of these
expansions still remains relatively modest.
HOX genes are involved in the regulation of hemato-Summary
poiesis (reviewed in Magli et al., 1997) and contribute
to the development of human leukemias (reviewed inWe previously showed that HOXB4 is a potent stimula-
Buske and Humphries, 2000). There is a growing bodytor of hematopoietic stem cell (HSC) proliferation in
of evidence suggesting that HOXB4 displays interestingvivo and ex vivo. As a result, HOXB4 overexpressing
properties in hematopoiesis. For example, in a mouseHSCs are 20- to 50-times more competitive than un-
bone marrow (BM) transplantation model, retroviraltransduced cells when transplanted into mice. By
overexpression of HOXB4 induced up to a 1000-fold netknocking down the expression of PBX1 (PBX1K.D.) in
increase in the number of transduced HSCs (AntonchukHOXB4 overexpressing cells, we now present the pos-
et al., 2001; Sauvageau et al., 1995; Thorsteinsdottir etsibility of generating HSCs that are 20-times more
al., 1999). It also promoted a significant increase in thecompetitive than those that overexpress HOXB4. The
rate and the magnitude of hemopoietic reconstitutiondifferentiation activity of these cells appears intact,
when compared to cells transduced with a control ret-since they competitively contributed to the reconstitu-
roviral vector (Antonchuk et al., 2001). Recent studiestion of normal myeloid and lymphoid compartments
have also demonstrated that HOXB4 induced a rapidin vivo. We also show that the in vivo expansion of
40-times net ex vivo expansion of mouse HSCs (Anton-HOXB4-PBX1K.D.-expressing HSCs regenerated nor-
chuk et al., 2002). The enhanced expansion of HOXB4-mal stem cell pools and did not lead to HSC levels
transduced HSCs occurs without impairing the normalabove those detected in unmanipulated mice. The vig-
production of mature cells. Moreover, leukemic transfor-orous competitive nature of these cells in vivo com-
mation has never been observed in long-term recipientspared to HOXB4-transduced HSCs suggests the exis-
of HOXB4-transduced cells. Recent studies indicate that
tence of a distinct, non-cell autonomous mechanism
HOXB4 has similar potent growth enhancing effects on
that limits the expansion of HOXB4-transduced hemo- primitive human cells (Buske et al., 2002).
poietic stem cells in mice. In this study we sought to further enhance the expan-
sion of HSCs engineered to overexpress HOXB4. Ongo-
Introduction ing studies in our laboratory indicate that the DNA bind-
ing capacity of HOXB4 is required to enable HSC
Successful therapeutic applications of hematopoietic expansion (N.B., J.K., and G.S., unpublished data). While
stem cell (HSC)-based transplantation depend on both further investigating other potentially important interac-
the initial numbers and subsequent expansion of the tions, we explored the HOXB4-PBX interaction. These
transplanted HSCs. Limiting initial numbers may be studies showed that a HOXB4 point mutant protein lack-
problematic in several situations, such as in the use ing the capacity to form cooperative DNA binding with
of cord blood in adults or after the extensive in vitro PBX proteins retains the capacity to induce similar
manipulations associated with gene transfer proce- expansion of HSCs as wild-type HOXB4, thus sug-
dures. In a number of clinical settings, such as trans- gesting that PBX is not required for the distinct HOXB4
plantation into non-myeloablated hosts and many gene activity in HSC. Surprisingly, parallel experiments where
therapy applications, the ability of the transplanted we engineered suppression of PBX expression with anti-
HSCs to overcome residual stem cells could offer signifi- sense methods revealed that PBX might actually be
suppressing or limiting the growth-enhancing effects of
HOXB4. We examined this possibility in detail and report*Correspondence: guy.sauvageau@ircm.qc.ca
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that knock down of endogenous PBX1 protein (PBX1K.D.) PBX1 Levels Determine the In Vitro Proliferation
expression in HOXB4-overexpressing cells generates Potential of BM Cells Overexpressing HOXB4
HSCs that are at least 20-times more competitive than We previously showed that HOXB4 overexpression con-
those engineered to overexpress HOXB4 alone. The fers a significant in vitro proliferation advantage to trans-
PBX1K.D. HOXB4-expressing HSCs show normal in vivo duced BM cells (Antonchuk et al., 2002). Using an in
differentiation and do not override the endogenous vitro competitive proliferation assay initiated with four
mechanisms that regulate the maximum number of different populations of transduced BM cells (Figure 2A),
HSCs present in a mouse and do not cause leukemia HOXB4-PBX1K.D. BM cells expanded much better than
or myeloproliferation. HOXB4 cells: within 3 days, the proportions of HOXB4-
PBX1K.D. cells (black squares) increased by approxi-
Results mately 2-times above the values determined for HOXB4
cells (Figure 2A, gray triangles), and by day 9 became
Knocking Down PBX1 Levels in Primary Bone the predominant cell type, representing over 60% of the
Marrow Cells population. In contrast, the proportion of PBX1K.D. (YFP)
Experiments were performed to test the possibility that cells behaved similarly to control cells, decreasing
reducing levels of PBX gene products might further en- steadily with time in culture and becoming barely detect-
hance the HOXB4-induced expansion of HSC. To deter- able by day 12 (Figure 2A). This clearly indicates that
mine which of the PBX proteins might be involved in PBX1K.D. cells had no proliferative advantage over non-
the regulation of HSC behavior, we first measured, by transduced cells. The in vitro expansion of colony-form-
semiquantitative RT-PCR, the relative mRNA levels of ing cells (CFC) derived for each of the four populations
all three known PBX genes expressed in a phenotypi- (i.e., HOXB4-PBX1K.D. HOXB4; PBX1K.D.; untransduced)
cally pure subpopulation of bone marrow cells highly was assessed in liquid cultures initiated with equal num-
enriched for HSC activity. Although expressions of all bers of sorted GFP, GFP/YFP, YFP, and GFP–/YFP–
three PBX genes were detected in the primitive fraction cells. By day 12 of the culture, HOXB4-PBX1K.D. CFC
(Sca1Lin–), the expression of PBX1 appeared predomi- increased 2.5-times above the levels determined for
nant (Figure 1A). HOXB4 cells (Figure 2B), for a net 1600-fold expansion
Our previous studies demonstrated that retroviral over their initial numbers. Expansion of PBX1K.D. CFC
transduction of antisense cDNA to PBX1 represented a was similar to that seen with untransduced cells (i.e., 6-
very effective tool to suppress endogenous levels of this to 7-times).
protein (Krosl et al., 1998). Mouse bone marrow cells Importantly, the competitiveness of HOXB4-PBX1K.D.
were infected with either recombinant retroviruses en- as compared to HOXB4 overexpressing cells was not
coding antisense PBX1 cDNA and yellow fluorescent due to a negative feedback mechanism, since the latter
protein (a/s PBX1-YFP), or HOXB4 and green fluorescent expanded similarly whether they were grown in the pres-
protein (HOXB4-GFP), or with a combination of both ence or absence of HOXB4-PBX1K.D. cells (data not
vectors (see Figure 1B for description of vectors). Repre- shown).
sentative examples of gene transfer efficiencies, assessed
by flow cytometric analyses of YFP and GFP expression,
The Repopulating Potential of HOXB4 Cells Is
are shown in Figure 1C. Gene transfer efficiencies for
Enhanced by Reducing Levels of PBX1
single a/s PBX1-YFP and HOXB4-GFP infections were
Two different groups of BM transplantation chimeras45%–70% and 60%–75% (n 3), respectively. In popu-
were generated by transplanting a mixture of HOXB4lations of cells coinfected with a/s PBX1-YFP and
cells with untransduced cells (Group I), and a mixtureHOXB4-GFP, the efficiencies of double infection (YFP/
of the same four cell populations detailed in the previousGFP) were 9%–14%, and singly infected cells (i.e.,
section (Group II, see Figure 3 for details). The relativeYFP or GFP) represented 35%–44% and 12%–15%,
contribution of each subpopulation to the bone marrowrespectively, of total cell populations. Southern blot
graft for each group is indicated in Figure 3 (t  0:analyses of proviral integrations in DNA isolated from
representative group of four mice) and summarized forclonal populations derived from sorted GFP/YFP and
all three experiments in the histograms at the bottomGFP cells (Figure 1C, right panel) confirmed that all
of the Figure (see t  0, bottom panels of Figure 3). InGFP/YFP clones originated from [HOXB4-GFP  a/s
Group I recipients (inoculum comprised 10% HOXB4-PBX1-YFP]-transduced progenitors (Figure 1C, upper
GFP-transduced cells), GFP cells represented 25 right panel) and that GFP cells comprised only HOXB4-
4% of PBL at 7 weeks postreconstitution as shown byGFP-transduced cells (Figure 1C, lower right panel).
FACS profiles of four representative recipients (FigureWestern blot analyses showed that both GFP and
3, left middle panel), and increased to 42 6% by weekGFP/YFP populations expressed high levels of
30 (Figure 3, left bottom panel). This clearly demon-HOXB4 protein (Figure 1D, top panel) and that the anti-
strates the repopulating advantage of these cells. Con-sense approach was effective in knocking down levels
trol GFP-transduced cells in similar conditions reconsti-of PBX1 protein in the GFP/YFP BM cells (Figure 1D).
tuted less than 3% of the hematopoietic system at theReductions in levels of Pbx1 had little impact on protein
same points in time (N.B., J.K., and G.S., unpublishedlevels of Hoxb4 (see different clones in Figure 1D, right
data).panel). For simplicity, cells expressing lower levels of
Group II recipients received a mixture of (1) HOXB4-PBX1 as a result of the antisense retroviral vector will
PBX1K.D. (2) HOXB4-overexpressing; (3) PBX1K.D. and (4)be identified as “PBX1K.D.” (for knock down PBX) and
untransduced cells (Figure 3, right panel, top). A sum-those engineered to express HOXB4 and antisense
PBX1 as “HOXB4-PBX1K.D.” cells. mary of the graft composition for 14 different primary
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Figure 1. Expression of PBX1 in Normal and a/s PBX1-Transduced Adult Bone Marrow Cells
(A) PBX gene expression in primitive subpopulations of mouse BM cells. Total RNA isolated from various subpopulations of BM indicated
was subjected to reverse transcription and global amplification. Probes used for Southern blot analyses of the amplified cDNAs are indicated
to the left and exposure times of autoradiograms to the right of figure. Note that exposure time for PBX3 was thrice as long as those for
PBX1 and PBX2 despite using probes with similar GC content.
(B) Schematic representation of retroviral vectors used in this study. Restriction sites relevant for this study: K, KpnI; E, EcoRI; H, HindIII.
(C) Left panel, Flow cytometric analyses of YFP, GFP and YFPGFP expression in populations BM cells derived from 5-FU-treated mice 1
day after harvest from cocultures with a/s PBX1(YFP), HOXB4(GFP), and a/s PBX1 plus HOXB4 (GFP and YFP) retrovirus-producing cells.
Right panel, Southern blot analyses to detect Hoxb4 or a/s PBX1of proviruses in DNA isolated from clonal populations initiated with GFP/
YFP (right top panel) or GFP (right lower panel) cells. DNA isolated from these clones was digested with KpnI, which releases the 4.4 kb
a/s PBX1-YFP proviral genome, and cuts in LTRs and IRES of HOXB4-GFP provirus to generate the 2.3 kb HOXB4- and the 1.7 kb GFP-
comprising fragments. Probes used are indicated to the right. Arrows to the left of the upper-right panel denote positions of bands representing
proviral integrations, and arrowheads show bands corresponding to endogenous HOXB4 and PBX1 genes. CTRL, normal BM.
(D) Western blot analyses of PBX1 protein levels in control, HOXB4, and HOXB4-PBXK.D. BM cells. Left panel, polyclonal populations 5 days
after recovery from coculture with retrovirus-producing cells. Right panel, individual clones isolated from methylcellulose cultures initiated
with BM derived from primary recipients sacrificed at 16 weeks posttransplant. Antibodies used are listed to the right. c-Jun levels are shown
as a loading control.
recipients (from three different experiments) is shown PBX1K.D. cells was detected in mice transplanted with
mixtures of bone marrow cells recovered from cocul-at the bottom of the right panel in Figure 3 (t  0). In
all cases HOXB4-transduced cells and HOXB4-PBX1K.D. tures with retrovirus-producing cells as previously de-
scribed, as well as in recipients of grafts comprised ofcells each represented 10% of the inoculum and
PBX1K.D. cells 25%. The proportions of YFP/GFP 10% of sorted YFP/GFP and 10% of sorted GFP
cells mixed with nontransduced competitors (one exper-cells (representing the HOXB4-PBX1K.D. cells) increased
from10% to 32 6% by week 7 (Figure 3, right panel, iment, four mice analyzed at 25 weeks posttransplanta-
tion, Figure 3, right panel, bottom). Although YFP cellscenter), and to 51  7% by week 30, while proportions
of GFP cells (HOXB4 cells) rarely increased above the (PBX1K.D. cells) represented up to 28% of the initial graft,
their numbers decreased to less than 7% at early pointsinitial 10% (black bars in Figure 3, right panel, bottom).
This competitive repopulation advantage of HOXB4- in time and became undetectable beyond 12 weeks after
Immunity
564
Figure 2. PBX1 Levels Determine the In Vitro
Proliferative Capacity of HOXB4-Transduced
Primary Bone Marrow Cells
(A) Expansion in liquid cultures of different
populations of BM cells transduced 24 hr ear-
lier with the indicated retroviruses. A repre-
sentative experiment is shown.
(B) In vitro expansion over a 12 day period
of myeloid CFCs derived from the indicated
populations of transduced BM cells. Results
represent mean values  SD of three inde-
pendent experiments.
transplantation (white bars in Figure 3, right panel, bot- of these organs is shown in Figure 4A for four mice
(16 weeks posttransplantation). GFPYFP (HOXB4-tom). YFP–/GFP– (i.e., untransduced) cells seemed to
account for up to 50% of the reconstitution. However, PBX1K.D.) cells that represented about 1/10th of the bone
marrow graft accounted for 60%–75% of BM- andas shown below, the vast majority of CFCs originated
from HOXB4-PBX1K.D. or HOXB4 cells, thus suggesting spleen-derived Mac-1 cells, 45%–75% of BM- and
spleen-derived B cells, and 80%–85% of CD4/CD8that either expression levels of marker genes in the ap-
parently GFP–YFP– PBL remained below the threshold thymocytes (Figure 4A, gray bars). Consistent with the
low proportion of GFPYFP– (HOXB4-transduced) cellsof FACS detection, or that a proportion of the reporter
genes in the integrated proviruses were inactivated. in the peripheral blood from these mice, only a minor
representation (5%–7%) of these cells could be de-All Group I and II primary recipients remained healthy
for up to 9 months of observation and had normal num- tected in the BM, spleen, and thymus from these primary
recipients (Figure 4A, black bars).bers and distribution of myeloid and lymphoid cells in
their bone marrow, spleen, and thymus (not shown). The As often seen in recipients of HOXB4-transduced cells
(Sauvageau et al., 1995; Thorsteinsdottir et al., 1999),proportion of cells expressing GFP and/or YFP in each
Figure 3. Competitive Reconstitution by
HOXB4- and HOXB4-PBX1K.D.-Transduced
Cells
Left panel, Group I: Competitive reconstitu-
tion with HOXB4-transduced BM cells. Top:
t  0, transplant composition; center: repre-
sentative FACS profiles from four mice show-
ing that, at 7 weeks posttransplant, the pro-
portions of GFP(HOXB4) transduced
circulating leukocytes increased 2.5-times
above the input level; bottom: proportions of
GFP(HOXB4) transduced cells in peripheral
blood of mice (n  12, three experiments)
transplanted with inocula (t  0) comprising
10% GFP(HOXB4) transduced cells. Results
represent mean values  SD for proportions
of GFP(HOXB4) PBL determined by flow cy-
tometry at the indicated times after trans-
plantation. Numbers of mice analyzed per point
in time are shown above bars representing pro-
portions of GFP PBL. Right panel, Group II:
competitive reconstitution with HOXB4 and
HOXB4 plus a/s PBX1-transduced cells. Top:
t  0, transplant composition for representa-
tive group of four recipients; Center: FACS pro-
files depict increase in proportions of YFP/
GFP(a/s PBX1HOXB4) circulating leuko-
cytes above the levels determined for
GFP(HOXB4) cells at 7 weeks posttrans-
plant. Bottom: proportions of GFP(HOXB4),
YFP/GFP(a/s PBX1HOXB4), and YFP(a/s
PBX) cells in recipients at various times post-
transplant. Graph shows mean values  SD
for the number of mice (shown above bars)
analyzed at the given time. Mice analyzed at
12 and 30 weeks posttransplantation received
bone marrow grafts as described above. For mice analyzed at 25 weeks posttransplant (n  4*), inoculum comprised 10% of sorted
GFP(HOXB4) and 10% of YFP/GFP(a/s PBX1HOXB4) bone marrow cells.
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Figure 4. Hemopoietic Reconstitution of Recipients of Composite Grafts Comprising HOXB4 and HOXB4-PBX1K.D.-Transduced BM Cells
(A) Flow cytometric analysis of hematopoietic cells from BM, spleen, and thymus of mice transplanted with comparable proportions of HOXB4
(GFP) and a/s PBX1  HOXB4 (GFP/YFP)-transduced BM cells (Figure 3, right panel, Group II). Proportions of GFP, YFP, and GFP/
YFP cells in myeloid (Mac-1) and lymphoid (B-220 and CD4/CD8) populations were determined for mice sacrificed at 16 (n  3) and 32 (n  1)
weeks posttransplantation.
(B and C) CFC content (B) and distribution (C) in BM and spleen of recipients described in (A). For (C), differential counts were performed on
6–8 methylcellulose cultures comprising 50–60 BM-, or 20–30 spleen-derived CFCs. Colonies were scored as containing predominantly
granulocytes (G), granulocytes and macrophages (GM), macrophages (M), erythroblasts (E), or a combination of these cells together with
megakaryocytes (mix).
(D) Southern blot analysis of proviral integrations in DNA isolated from myeloid clones derived from Group I and Group II recipients described
above. 15–20 different clones from each mouse were isolated and analyzed. DNA was digested with EcoRI, which cuts once within HOXB4
and a/s PBX1 provirus such that each autoradiographic band represents a unique integration event. Arrowheads at the left show bands
representing endogenous HOXB4 and PBX1. Donor mice and the corresponding clones are indicated at the top, and probes used are listed
to the right of blots.  and/or – at the bottom identify clones positive for HOXB4 and PBX1 provirus integration. Southern blot analyses of
representative clones (4/15 and 3/12) are shown.
(E) Western blot analysis of HOXB4 and PBX1 protein levels in myeloid clones isolated from Group II recipients. CTRL, clone negative for
HOXB4 and PBX1 integration; HOXB4, clone harboring only HOXB4 provirus (left panel, clone #2.1) Clone numbers indicated at the top
identify clones genotyped in the left panel.
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these complex hematopoietic chimeras had slightly ele- cause none of the numerous secondary recipients (n 
90) were reconstituted with a CRU derived from PBX1K.D.vated numbers of spleen myeloid and B lymphoid col-
populations, although they represented 25% of theony-forming cells (CFCs) (not statistically different with
cells transplanted per primary recipient. For Group IIthe number of mice analyzed: n  6) (Figure 4B). The
recipients, CRU frequencies were also determined at 32distribution of the various types of CFCs was not differ-
weeks posttransplantation and found to be similar toent between GFP or YFP and control cells (Figure 4C).
those at 16 weeks, indicating that the expansion ofSince it was impossible to distinguish by epifluores-
HOXB4-PBX1K.D. CRUs had stabilized over time. The re-cence between GFP and/or YFP-expressing cells, we
sults of these CRU assays indicate that the major in vivoanalyzed DNA, isolated from individual randomly
competitive advantage of HOXB4-PBX1K.D. over HOXB4plucked colonies, for the presence of the integrated
cells occurred at the HSC level.HOXB4 and a/s PBX1 provirus (Figure 4D, representative
Southern blot analyses of proviral integrations in DNAclones). In total, 44/53 or 80% of myeloid CFCs derived
isolated from the BM, spleen, and thymus of primaryfrom three recipients originated from doubly transduced
recipients, and from the corresponding secondary recip-cells (HOXB4-PBX1K.D.), and only 4/53 or 7% from
ients used for CRU assays, were performed (Figure 5B)HOXB4-transduced cells. Western blot analysis showed
to verify that the regeneration of HOXB4-PBX1K.D. CRUsthat clones derived from HOXB4-transduced cells ex-
in our hematopoietic chimeras was indeed mediated bypressed high levels of HOXB4 protein, while HOXB4-
pluripotent doubly transduced HSCs, and to determinePBX1K.D. clones expressed HOXB4, but no detectable
the number of cellular clones that contributed to thisPBX1 (Figure 4E, representative nontransduced, HOXB4-
reconstitution. To facilitate distinction between the twoand HOXB4-PBX1K.D. clones). Surprisingly, only 5/53 or
integrated proviruses (i.e., HOXB4-GFP and a/s PBX1-9% of randomly generated clones didn’t have either
YFP), DNA was digested with EcoRI and HindIII, whichHOXB4 or a/s PBX1 provirus, suggesting a minimal con-
cut the HOXB4-GFP provirus upstream of GFP. In thistribution of nontransduced transplant-derived and en-
way, each proviral integration generated a distinct auto-dogenous host cells to hematopoietic reconstitution.
radiographic band (clonal analysis) and also released aTogether, these results indicate that (1) HOXB4-
3 kb PBX1-YFP cassette from the a/s PBX1 provirusPBX1K.D. cells in vivo were much more competitive than
(see Figure 1B for a diagram representing the two retro-HOXB4-transduced cells; (2) HOXB4-transduced cells
viruses and see Figures 5B and 5C for the commonwere more competitive than nontransduced or PBX1K.D.
signal at 3 Kb).cells; (3) the repopulation advantage conferred by
In the BM, spleen, and thymus of primary and second-PBX1K.D. occurred only in the context of HOXB4 overex-
ary recipients transplanted with 5  103 –1  106 cells,pression. These studies, however, did not clarify
multiple HOXB4 proviral integrations were detected.whether the in vivo competitive advantage of HOXB4-
Variations in autoradiographic intensities of these bandsPBX1K.D. cells occurred at the level of stem cells or in
suggest that multiple cellular clones (at least 4, Figuresmore mature progenitors.
5B and 5C, a, b, c, and d), rather than a few clones with
several proviral integrations, contributed to the reconsti-In Vivo Expansion of HOXB4-PBX1K.D. HSCs
tution of these tissues. The pluripotent nature of recon-
The in vivo expansion of HOXB4-PBX1K.D. stem cells was
stituting HSC becomes apparent in mice transplanted
assessed using the CRU (competitive repopulation unit)
with 1 CRU (Figure 5B, right panel), where the same
assay (Sauvageau et al., 1995; Szilvassy et al., 1990; proviral integration pattern can be detected in the BM
Thorsteinsdottir et al., 1999) and compared to the and thymus of secondary recipients 1.2.A, 1.2.B, and
expansion of HOXB4-transduced cells within the same 1.2.D. In addition, self-renewal division in primary recipi-
recipient. At 16 weeks posttransplantation, BM cells ents of several of these clones was documented, since
were harvested from the hematopoietic chimeras (Group one cellular clone repopulated more than one secondary
II) and transplanted, in increasing dilutions, into second- recipient (see, for example, clone a or d in several of
ary recipients. The contribution of the transduced (either the mice, Figures 5B and 5C). To complement this study,
GFP, GFP/YFP, or YFP) cells to lymphoid and my- DNA was also isolated from colonies derived from BM
eloid reconstitution of secondary recipients was deter- progenitors of these mice. A total of 36 myeloid clones
mined by flow cytometry at 16 weeks posttransplanta- were analyzed from the various secondary mice pre-
tion and estimation of CRU numbers was performed sented in Figure 5B, and a Southern blot analysis re-
using the maximum likelihood method as described vealed that all (36/36) originated from doubly transduced
(Szilvassy et al., 1990). At that time (16 weeks), the fre- HSCs (Figure 5C, representative analysis). Similar re-
quency of HOXB4-PBX1K.D. CRU was 1/17,500 (Figure population outcomes were determined for all three pri-
5A). Considering that the hematopoietic system of an mary recipients that were analyzed.
adult mouse contains 2  108 cells, this represented The proliferative potential of individual CRU can be
approximately 104 CRU per mouse. Since our primary estimated in mice transplanted at limiting dilution, where
recipients received approximately 10 HOXB4-PBX1K.D. the activity of single CRU contributes to the production
CRUs (see Table 1), these data suggest a net expansion of 1%–5% of mature myeloid and lymphoid cells. Flow
of up to 1000-fold for HOXB4-PBX1K.D. CRUs. CRU fre- cytometric analyses of secondary recipients from Group
quency of HOXB4-transduced cells from these same II primary mice revealed that, at limited dilution, HOXB4-
primary recipients was estimated at only 1/430,000 cells, PBX1K.D. CRUs generated on average 4  2% GFP/
representing at best 500 CRU in these mice for an YFP PBL (mean value  SD, n  45). The competitive
estimated expansion in the range of 50-times. CRU fre- nature of HOXB4-PBX1K.D. HSCs was thus not due to an
increased output of individual stem cells but rather toquency of PBX1K.D. cells could not be determined be-
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Figure 5. Decrease in PBX1 Levels Increases the Competitive Repopulation Potential of HOXB4-Transduced HSCs
(A) Limiting dilution analysis for estimation of CRU frequency in primary Group II recipient mice (Figure 3, right panel, n  2).
(B) Southern blot analysis of proviral integrations in DNA isolated from the BM, spleen, and thymus of selected primary and secondary
recipients (Figure 3, Group II) sacrificed 16 weeks posttransplantation. DNA was digested with EcoRI and Hind III, which generate a 3 kb a/s
PBX-YFP fragment, and release HOXB4 cDNA from HOXB4-GFP provirus, such that the GFP region of provirus denotes a distinct proviral
integration event on blots probed with GFP. Right panel, dashed line denotes position of provirus-derived PBX1 fragment, and different
integrations for HOXB4 provirus are labeled as a and b (also c and d in [C]). The numbers of BM cells and estimated numbers of CRUs
transplanted in the secondary recipients are shown. The proportions of GFP and YFP/GFP PBL detected in these mice are listed below
each lane.
(C) Southern blot analysis of proviral integrations in DNA isolated from myeloid clones generated from secondary recipients presented in (B).
Figure shows analysis of 13 clones derived from recipients 1.1.B, 1.2.A, 1.2.B, and 1.2.C presented in (B). Each secondary mouse and the
corresponding myeloid clones are identified by numbers at the top of the blot. C-, control DNA derived from nonmanipulated mouse. Dashed
area, as in (B).
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Table 1. CRU Recovery at 16 Weeks Posttransplantation
Group I Group II
Number of transplanted CRUa (95% CI) 90 (61-152) 110 (70-175)
Composition of transplantb GFP 12 14
GFPYFP — 11
YFP — 30
GFP–YFP– 80 51
CRU frequency (95% CI)c GFP 1/26,000 1/430,000
(1/19,600-1/35,800) (1/328,600-1/566,400)
GFPYFP — 1/17,500
(1/13,200-1/23,100)
YFP — 1/1,000,000
GFP–YFP– ND ND
CRU/moused GFP 7,600 (5,586–10,204) 450 (353 - 609 )
GFPYFP — 11,500 (8,658-15,151)
YFP — 200
GFP–YFP– ND ND
Percentage of normal GFP 76 4.6
GFPYFP — 110
YFP — 2
GFP–YFP– ND ND
a CRU frequency in 5-FU derived BM cells after 2 day prestimulation was 1/2700 (1/1680 to 1/4218, 95% CI). Numbers of transplanted CRU
represent progeny of cells introduced into coculture with retroviral producers.
b Proportions of transduced CRU were calculated from infection efficiencies determined by flow cytometric analysis of GFP, YFP, and GFPYFP
expression by BM cells 1 day after recovery from coculture with retroviral producers.
c CRU frequencies represent mean values determined for two (group I) and three (group II) recipients using limiting dilution analysis.
d Values shown were calculated from CRU frequencies, and assumption that one femur represents 10% of total BM.
a preferential and competitive expansion of the stem Discussion
cell population in these primary recipients.
HOXB4 has been characterized as a unique factor, capa-
ble of inducing considerable in vivo and ex vivo expan-
Understanding the Competitive Nature of HOXB4- sions of HSCs. Results presented in this report demon-
PBX1K.D. versus HOXB4-Transduced HSCs: Evidence strate that the HOXB4-specific capacity to competitively
for Strict Controls of the Maximal HSCs Pool Size expand HSCs can be further increased by 20-times
As shown in Figure 5A and Table 1, CRU frequency of using an antisense approach to PBX1. This effect was
the various populations varied considerably in our mixed observed on numerous clones isolated from several
chimeras, from 1/17,500 cells for HOXB4-PBX1K.D. cells mice. All recipients of HOXB4-PBX1K.D. HSCs remained
to 1/430,000 cells for HOXB4-transduced cells. The healthy and without any detectable sign of hematopoi-
number of HOXB4-transduced CRU detected in HOXB4- etic disease for up to 9 months of observation, demon-
PBX1K.D. versus HOXB4 competitive set up (Figure 6, strating that the transduced HSCs, which underwent
right panel, black bar) was much lower than values deter- a significant in vivo expansion, remained functionally
mined for Group I recipients reconstituted with 10% unimpaired. These characteristics, coupled with the
HOXB4-transduced cells and 90% untransduced cells ability of HOXB4 to promote ex vivo expansion of HSC
(Figure 6, left panel, black bar), or the values determined (Antonchuk et al., 2002), may have major implications
in our previous experiments (Antonchuk et al., 2001, on the development of new stem cell transplantation
2002; Sauvageau et al., 1995; Thorsteinsdottir et al., strategies. On a more fundamental basis, these studies
1999). Frequencies of HOXB4-PBX1K.D. CRUs in Group revealed that the expansion of HOXB4-overexpressing
II mice were, however, comparable to the values deter- cells in vivo can be inhibited in the presence of a more
mined for the HOXB4-transduced CRUs in Group I recip- competitive population such as HOXB4-PBX1K.D. cells.
ients (Figure 6, compare black bar in left panel to gray In this competitive setting, HOXB4-transduced cells
bar in right panel), and to the previously reported values, failed to exert their stem cell expanding capacity and
and were at least 20-times higher than the frequencies regenerated only a minor fraction of HSC pool in recipi-
of HOXB4 cells within the same recipient (Figure 6, right ents. Interestingly, the highly competitive HOXB4-
panel). In competition with cells possessing a superior PBX1K.D. HSC did not repopulate the HSC pool size to
reconstitution potential (i.e., HOXB4-PBX1K.D. CRUs), the values greater than those observed with HOXB4-trans-
HOXB4-transduced CRUs thus limited their expansion duced cells, but did so to the values that characterize
to levels normally seen with untransduced cells, sug- normal, unmanipulated animals, indicating the presence
gesting the existence of a mechanism that regulates the of a non-cell autonomous mechanism that regulates of
total size of the HSC compartment in mice. the number of HOXB4-transduced HSC in vivo.
These studies demonstrate a new avenue in HOXB4- The mechanism(s) that limit the in vivo expansion of
induced stem cell expansion and reveal a non-cell au- HOXB4-PBX1K.D.- and HOXB4-transduced cells remain
tonomous mechanism that limits the expansion of to be identified. The proliferation rates of HOXB4-trans-
duced cells cultured in the presence or absence ofHOXB4-transduced cells in vivo.
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tween HOXB4 and PBX. Based on these results, it is
reasonable to imply, at this stage, that at least a part of
the HSC-expanding capacity of HOXB4 occurs through
direct regulation of target genes by HOXB4 protein. In
addition, since the HOXB4-PBX1K.D. cells in vivo behave
similarly to cells transduced with HOXB4 (e.g., maximal
in vivo expansion, normal differentiation, limited expan-
sion of spleen progenitors, no leukemia, etc.) it can be
argued that high levels of HOXB4 are sufficient to acti-
vate the pathway or set of targets involved in stimulation
of stem cell renewal. HOX monomers exhibit weak in
vitro transcriptional activity (Shen et al., 2001) but were
reported to be capable of directly suppressing c-myc
transcription in HL-60 cells (Pan and Simpson, 1999,
2001). HOXB4 seems to repress transcription of the
p21ras antagonist Rap1 in Xenopus embryos (Morsi El-
Kadi et al., 2002). We reported previously that HOXB4
overexpression correlates with the activation of Jun-B
and Fra-1 expression and subsequent upregulation of
cyclin D1 levels (Krosl and Sauvageau, 2000). The prolif-
erative potential of HOXB4 is thus at least partially con-
tingent on the HOXB4’s ability to enhance the ras-MAP
kinase-dependent activation of AP-1 complex by direct
inhibition of Rap1 expression. In HOX/PBX hetero-
dimers, HOX partner was reported to bind coactivator,
Figure 6. Comparison of the Competitive Expansion of HOXB4- while PBX interacts with corepressor complex, and the
PBX1K.D. versus HOXB4 HSCs in Primary Recipients switch from repressor to activator state was proposed
Comparison of CRU recovery following competitive reconstitution to be regulated by extrinsic stimuli (Saleh et al., 2000).
of Group I (left panel, HOXB4 versus nontransduced cells; see also Reduction of PBX levels could thus prevent formation
left panel in Figure 3) and Group II (HOXB4 versus PBX1K.D.HOXB4
of the repressive HOXB4/PBX1 complexes at relevant(right panel, see also Group II, right panel in Figure 3) reconstitution.
target sites and diminish the role extrinsic factors play inCalculations of CRU contents were based on CRU frequencies
HOXB4-promoted cellular proliferation. Overexpressionshown in Table 1 and on assumption that BM content of one femur
represents 10% of the total bone marrow in a mouse. Black bars, of HOXB4 associated with a decrease in PBX1 levels
HOXB4 cells; gray bars, HOXB4-PBX1K.D. cells. could further enhance the proliferative potential of
HOXB4 indirectly, by preventing the collaboration of
PBX1 and endogenous HOX gene products in activation
HOXB4-PBX1K.D. cells were comparable, suggesting that
of targets that mediate the suppression of cellular prolif-
this mechanism may not be active during the ex vivo
eration, such as cyclin kinase inhibitor (CKI) p 21 (Brom-
expansion. Our study, however, did not directly assess
leigh and Freedman, 2000). Importantly, as shown in
the in vitro expansion of HOXB4-transduced HSCs cul- Figure 1D (right panel) and Figure 4E (compare HOXB4
tured in the presence and absence of HOXB4-PBX1K.D.- protein levels in lane 2 versus 3–6), the effects of low-
transduced HSCs, so that, at this point, the possibility ering levels of PBX1 on the competitive potential of
of some mechanisms that specifically limit self-renewal HSCs are not achieved by increasing levels of the over-
divisions of HOXB4-transduced HSC in vivo and in vitro expressed HOXB4 protein.
cannot be excluded. Consistent with previously reported observations
To develop methods for exploiting HOXB4 as an HSC- (DiMartino et al., 2001), PBX1K.D. cells showed no prolif-
specific mitogen it will be important to determine erative advantage; it is only in the context of HOXB4
whether the net 40-times ex vivo expansion of HOXB4- overexpression that the PBX1K.D. becomes extremely sig-
transduced HSC we reported recently (Antonchuk et al., nificant. Our observations thus suggest that the pro-
2002) can be further enhanced by as much as 20-times liferation associated with self-renewal of HSC can be
in the context of PBX1K.D.. It will also be interesting to modulated by a subset of HOXB4-responsive genes in
determine whether other approaches, such as PBX1 a PBX1-independent manner and indicate that PBX1
siRNA, could achieve effects comparable to the anti- acts as a negative regulator of HOXB4-induced HSC
sense approach reported herein. proliferation. PBX1/ mice could represent an alter-
Defining the target genes involved in HOXB4-induced native model for studying the role of PBX1 in HOXB4-
expansion of HSCs is rapidly becoming one of the key induced stem cell expansion. PBX1/ generates,
issues in stem cell biology. Our ongoing experiments however, embryonic lethal phenotype characterized by
show that a HOXB4 point mutant protein, lacking DNA generalized hypoplasia associated with the absence of
binding capacity, fails to induce HSC expansion, a spleen (DiMartino et al., 2001). Compensatory mecha-
whereas the mutant lacking the capacity to interact with nisms active during the development of PBX1/
PBX1 retains its full function (N.B., J.K., and G.S., unpub- embryos could affect a variety of intrinsic and extrinsic
lished data). Thus it can be argued that HOXB4-induced mechanisms involved in establishing a normal adult HSC
expansion of HSCs is DNA binding dependent, but is pool, and could thus alter the inherent responsiveness
of HSCs to HOXB4. Although the antisense approachlikely independent of the cooperative DNA binding be-
Immunity
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was maintained between 5  104 and 5  105 cells/ml. At the sameused in this study was clearly successful in producing
points in time, the relative contents of GFP, and YFP, and GFP/a major reduction in PBX1 levels (see Figures 1D and
YFPcells were determined by flow cytometry. To determine the in4E), and was specific enough not to affect the PBX2
vitro proliferation potential of the transduced myeloid CFC, GFP,
and PBX3 paralog levels (Figure 4E and data not shown), or YFP, or GFP/YFP cells were sorted 1 day after recovery from
the possibility that the expression levels of other pro- coculture with retroviral producers, and liquid cultures were initiated
and maintained as described above. After 6 and 12 days of growth,teins might be affected cannot be ruled out.
suitable aliquots of cultures were plated in methycelullose con-In conclusion, results of these studies show that de-
taining 10 ng/ml of IL-3, 10 ng/ml of IL-6, 50 ng/ml of SCF, and 5creasing the levels of endogenous PBX1 can further
U/ml of Epo (hereafter, standard methylcellulose). Colonies wereincrease the competitive proliferation potential of
scored on day 10. Cytokines used in these experiments were pre-
HOXB4-transduced HSC by 20-times. We show that pared at IRCM as COS-cell supernatants. All other media compo-
the proliferative effect of PBX1K.D. is mainly restricted nents were purchased from GIBCO/Invitrogen Corp. (Burlington, ON,
Canada).to the most primitive HOXB4-transduced hemopoietic
cells, that these cells expand up to, but not beyond, the
Flow Cytometrynormal HSC levels, and retain their capacity to generate
Cells isolated from BM, spleen, and thymus of transplantation chi-progeny committed to all hemopoietic lineages. Our ob-
meras were resuspended in PBS with 2% FCS and allophycocyaninservations also show that the presence of more competi-
(APC)-conjugated antibodies recognizing Mac-1, or B220, or CD4
tive HOXB4-PBX1K.D.-transduced populations decreases and CD8 cell surface markers (Pharmingen, Mississauga, ON). Fol-
the proliferation activity of HOXB4 cells, suggesting the lowing a 30 min incubation on ice, cells were washed 2 with PBS
existence of extrinsic mechanism(s) that control the ex- with 2% FCS, and fractions of GFP, YFP, and GFP/YFP cells
that express a given cell surface antigen were determined by flowtent of HOXB4-induced stem cell expansion.
cytometry using MoFlo (Cytomation, Fort Collins, CO). Data were
analyzed using Summit V3.1 software (Cytomation, Fort Collins, CO).Experimental Procedures
Ly 5.1 peripheral blood-derived MNC were identified using FITC-
conjugated anti-Ly 5.1 antibody (Pharmingen, Mississauga, ON).Animals
(C57Bl/6J x C3H/HeJ)F1-recipients and (C57Bl/6Ly-Pep3b x C3H/
HeJ)F1 congenic donor mice were bred at a specific pathogen free Competitive Repopulation and CRU Assays
(SPF) animal facility at the Clinical Research Institute of Montreal. All To determine the contributions of the transplanted transduced
animals were housed in ventilated cages and provided with sterilized (GFP, YFP, and GFP/YFP) HSC to hemopoietic reconstitution
food and acidified water. at various intervals posttransplantation, 50 l of blood obtained
from the tail vein was incubated with excess ammonium chloride
(StemCell Technologies, Vancouver, BC) to lyse erythrocytes, andRetroviral Vectors
the proportions of GFP, YFP, and GFP/YFP PBL were deter-Generation of the MSCV-IRES-GFP and MSCV-HOXB4-IRES-GFP
mined by flow cytometry. Mice that had greater than 2% GFP, orvectors were described before (Antonchuk et al., 2001). To generate
YFP, or GFP/YFP cells in both myeloid (SSChiFSClow) andthe MSCV-a/s PBX1b-PGK-YFP vector, a 1.4 kb fragment encoding
lymphoid (SSClowFSChi) subpopulations were considered to be re-PBX1b ORF was blunted and subcloned into HpaI site of MSCV-
populated with at least one transduced HSC. Fidelity of discrimina-PGK-YFP (Kroon et al., 2001).
tion between myeloid and lymphoid cells was verified using cell
surface staining to detect lineage-specific markers (Mac-1 versusRetroviral Infection and Transplantation of Primary Bone
B-220). HSC numbers in primary recipients were evaluated using aMarrow Cells
limiting dilution transplantation-based assay (CRU assay) that de-Generation of retrovirus-producing GPE-86 cells, and single or
tects cells with competitive, long-term lympho-myeloid repopulationdouble infections of bone marrow cells, were performed as pre-
capacity (Szilvassy et al., 1990). In brief, primary HOXB-GFP orviously described (Kroon et al., 2001). In brief, 1 day before the
HOXB-GFP plus a/s PBX1-YFP plus a/s PBX1-YFPHOXB4-start of BM infections GPE cells producing a/s Pbx1 or Hoxb4
GFP recipients were sacrificed at 16 or 32 weeks posttransplanta-retroviruses were replated at a density of 6–8  106 cells/10 cm
tion, and their bone BM were injected into lethally irradiated second-dish. For double BM infections, 3–4  106 of a/s Pbx1 and Hoxb4-
ary recipients at varying dilutions (5  103 –1  106 cells/recipient,transduced GPE cells were plated together to generate a mixed
5–10 recipients/dilution) along with 1  105 freshly isolated helperculture producing both retroviruses. Control competitor bone mar-
BM cells. The level of lymphoid and myeloid repopulation with do-row cells were cocultured with nontransduced GPE-86 cells but
nor-derived GFP, or YFP, or GFP/YFP cells in secondary recipi-were otherwise treated exactly like cells subjected to retroviral infec-
ents was evaluated at 16 weeks posttransplantation by flow cyto-tion. One day after recovery from coculture with retroviral producers,
metric analysis of PBL. CRU frequencies were calculated bythe proportions of transduced (GFP, YFP, or GFP/YFP) cells
applying Poisson statistics to the proportion of negative recipientswere determined by flow cytometry using MoFlo (Cytomation, Fort
at varying dilutions using Limit Dilution Analysis software (StemCellCollins, CO). Transplantation inocula comprising 10% GFP or YFP
Technologies, Vancouver, BC). The same type of analysis was ap-cells were prepared by diluting the infected cell populations with
plied to autoradiograms generated by Southern blot analysis ofnontransduced competitors. Doubly transduced (HOXB4-GFP, and
proviral integrations in DNA isolated from bone marrow and thymusa/s PBX1-YFP, and HOXB4-GFP a/s PBX1-YFP) cell populations
of recipients, in which the presence of HOXB4-GFP and/or a/s PBX1-were diluted with competitors so that the proportion of GFP/YFP
YFP provirus identified the reconstituted recipients. To determinecells always represented 10% of the transplants. 12- to 16-week-
CRU frequencies in BM populations introduced in coculture withold recipient mice were irradiated (850 cGy, 160 cGy/min,137Cs 	
retroviral producers (to), CRU assay was performed using 5-FU(J.L., Shepherd,CA) and transplanted with 2.5  105 cells, together
treated BM cultured for 2 days in media supplemented with IL-3 (6with 1  105 freshly isolated BM cells.
ng/ml), IL-6 (10 ng/ml), and SCF (100 ng/ml).
In Vitro Proliferation of Primary Bone Marrow Cells
To determine the in vitro competitive proliferation potential of the CFC Assays and In Vitro Expansion of Myeloid Clones
The frequencies of myeloid and pre-B clonogenic progenitors in BMtransduced cells, cultures comprised of varying proportions of
GFP, and YFP, and GFP/YFP bone marrow cell populations and spleen cell populations of primary and secondary recipients
were determined as described (Thorsteinsdottir et al., 2002). Towere initiated at 5  104 cells/ml in media supplemented with 15%
FCS and 20 ng/mL of IL-3 1 day after recovery from coculture with generate clonal myeloid cell populations, well isolated multilineage
mixed colonies were transferred from methylcellulose to liquid cul-retroviral producers. In 3 day intervals, viable (trypan blue negative)
cells were counted and diluted with fresh media so that cell density tures and expanded for 14 days in IMDM, supplemented with 15%
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FSC, IL-3 (10 ng/ml), IL-6 (10 ng/ml), IL-11 (100 ng/ml), SCF (100 cofactor and proto-oncogene Pbx1 is required for maintenance of
definitive hematopoiesis in the fetal liver. Blood 98, 618–626.ng/ml), and 105M 
-mercaptoethanol.
Gould, A., Morrison, A., Sproat, G., White, R.A., and Krumlauf, R.
Southern and Western Blot Analysis (1997). Positive cross-regulation and enhancer sharing: two mecha-
High molecular weight DNA from the BM, spleen, and thymus of nisms for specifying overlapping Hox expression patterns. Genes
transplantation chimeras and from myeloid clones was digested as Dev. 11, 900–913.
indicated in figure legends. Probes used were 600 bp (nt 930-1525 Karanu, F.N., Murdoch, B., Gallacher, L., Wu, D.M., Koremoto, M.,
of the ORF) PvuII fragment of PBX1, 490 bp SalI-PmlI fragment of Sakano, S., and Bhatia, M. (2000). The notch ligand jagged-1 repre-
HOXB4 cDNA, and 730 bp full-length YFP cDNA. Preparation of sents a novel growth factor of human hematopoietic stem cells. J.
total cell lysates and Western blot analyses were performed as Exp. Med. 192, 1365–1372.
described (Krosl and Sauvageau, 2000). Primary antibodies used
Kroon, E., Thorsteinsdottir, U., Mayotte, N., Nakamura, T., and Sau-were rat anti-HOXB4 (Gould et al., 1997, and Developmental Studies
vageau, G. (2001). NUP98-HOXA9 expression in hemopoietic stemHybridoma Bank, University of Iowa), rabbit anti-PBX1 and anti PBX3,
cells induces chronic and acute myeloid leukemias in mice. EMBOrabbit anti c-Jun, and horseradish peroxidase-conjugated anti-rat
J. 20, 350–361.and anti-rabbit antibodies (Santa Cruz Biotech., Santa Cruz, CA).
Krosl, J., and Sauvageau, G. (2000). AP-1 complex is effector of
Hox-induced cellular proliferation and transformation. Oncogene 19,cDNA Generation, Amplification and Analysis
5134–5141.Reverse transcription and amplification of total RNA isolated from
purified BM subpopulations were performed as described (Lessard Krosl, J., Baban, S., Krosl, G., Rozenfeld, S., Largman, C., and Sauva-
et al., 1998). Probes used were 600 bp PvuII fragment of PBX1 geau, G. (1998). Cellular proliferation and transformation induced
described above, 540 bp (nt 670-1210 of the ORF) PvuII fragment by HOXB4 and HOXB3 proteins involves cooperation with PBX1.
of Pbx2, 540 bp (nt 400-940) PvuII fragment of PBX3, and actin Oncogene 16, 3403–3412.
cDNA. Levels of gene expression were evaluated using Alpha Imager Lessard, J., Baban, S., and Sauvageau, G. (1998). Stage-specific
2000 Documentation and Analysis system (AlphaInnotech, San expression of polycomb group genes in human bone marrow cells.
Leandro, CA). Blood 91, 1216–1224.
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